UK based liquid medicines maker Rosemont Pharmaceuticals has appointed an American chief executive (CEO) as the business ...

AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) in combination with pertuzumab has been approved in the USA ...

The US Food and Drug Administration (FDA) yesterday removed a key limitation on the use of real-world evidence (RWE) used in ...

UK pharma major AstraZeneca today revealed that Saphnelo (anifrolumab) has been approved in the European Union (EU) for ...

UK-based Bicycle Therapeutics, a pharma company developing a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle) technology, has entered into a 15-year ...

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved pharma major GSK’s Exdensur (depemokimab), the first twice-yearly biological medicine for use as an add-on treatment for ...

Link Cell Therapies, an oncology cell therapy company, has announced its official launch from stealth with a $60 million ...

Italian non-profit rare and complex genetic diseases specialist Fondazione Telethon (FT) and Orphan Therapeutics Accelerator ...

As many as four out of 10 assessments of new drugs carried out by the Danish Medicines Council had the process stopped midway ...

The US Food and Drug Administration (FDA) has accepted the resubmission of its New Drug Application (NDA) for copper ...

Results from the PERSEUS Phase III study showed that tolebrutinib did not meet its primary endpoint in delaying time to ...

California-based Tenaya Therapeutics, a biotech seeking to discover, develop and deliver potentially curative therapies that ...